| Date | Title | Description |
| 07.05.2024 | Memo Therapeutics raises additional CHF20 million |
Schlieren-based Memo Therapeutics is a late-stage biotech company developing therapeutic antibodies for patients with viral infections and cancer. MTx’s lead program, AntiBKV, is a highly effective and safe neutralizing antibody to treat B... |
| 15.08.2023 | Dutch medtech firm Xeltis secures €12.5M from EIC Fund | Dutch medtech firm Xeltis has secured €12.5 million in funding from the European Innovation Council (EIC) Fund. This brings Xeltis' total amount raised, to date, to €44.5 million. Its investors include DaVita Venture Group, EQT Life Science... |
| 10.03.2023 | Belgium-based Sunrise bags €17M to help people suffering from sleep disorders | Belgium-based Sunrise, a healthtech company that claims to be revolutionising sleep analysis, announced on Thursday, March 9, that it has raised €17M in a fresh round of funding. This funding is in addition to €12M that the startup has alre... |
| 20.10.2022 | DeepUll cierra una ronda serie B de €13 M. liderada por CDTI. Participan Kurma, Alta LS, UI y Axis | 20/10/2022
Nota de prensa
DEEPULL LEVANTA 13 M€ EN UNA RONDA SERIE B PARA AVANZAR EN LA PLATAFORMA DE DETECCIÓN PRECOZ DE LA SEPSIS
DeepUll, una compañía dedicada al diagnóstico médico que desarrolla soluciones diagnósticas económicas y ... |
| 30.06.2022 |
Ermium Therapeutics extends its initial €6.3 M funding to €12.3 M to further advance breakthrough auto-immune disease therapeutics | Ermium Therapeutics, a Paris-based biotech company developing innovative health products for auto-immune diseases, announced today the extension of its initial funding of €6.3 M to €12.3 M with Kurma Partners and Fountain Healthcare Partner... |
| 30.06.2022 | French digital clinic Charles.co gets a shot of €7 million to make men’s health solutions more accessible | Paris-based digital clinic entirely dedicated to men’s health issues, Charles.co has brought in €7 million in a seed-stage funding. The funding will allow the startup to expand its offerings and build out its team, which has already support... |
| 04.02.2022 | Parisian startup revolutionising skin cancer screening raises €5 million to accelerate European rollout | Skin cancers affect over 5 million people worldwide each year and patient prognosis continues to be highly dependent on the timing of diagnosis. Attempting to speed up the diagnosis process is Paris-based medtech company Damae Medical. It h... |
| 20.04.2021 | Synendos Therapeutics raises additional funds in Series A | |
| 20.04.2021 | Synendos Therapeutics raises additional funds in Series A | Synendos is a biopharmaceutical company developing a new class of small molecules aimed at restoring the natural functioning of the endocannabinoid system in the brain with the potential for treating a wide range of Central Nervous System (... |
| 25.03.2021 | French biotech company Step Pharma raises €35 million in Series B | Step Pharma, a Paris based biotech company, announced on 24th March 2021 that it has raised €35 million in its Series B funding round. The round was led by Sunstone Life Science Ventures and Hadean Ventures, along with participation from Ku... |
| 02.03.2021 | Mesoblast gets a $110M lifeline from SurgCenter Development; uniQure still unsure if gene therapy spurred cancer event | Mesoblast faced rough waters in 2020, but on Monday were thrown a financial lifeline.
The Australian stem cell therapy player has raised $110 million in a private placement, the company announced, offering 60 million share... |
| 12.11.2020 | Synendos Therapeutics secures CHF 20 million | Incorporated in April 2019 as a spinoff of the University of Bern and the research consortium, NCCR TransCure, Synendos Therapeutics co-founded by professor Jürg Gertsch and Andrea Chicca (CEO) is focused on introducing a breakthrough appro... |
| 12.11.2020 | Synendos Therapeutics secures CHF 20 million | |
| 07.07.2020 | DeepUll cierra una ronda de €3,5M liderada por Alta Life Sciences y Kurma. Participan Axis y Sofimac | 07/07/2020
Nota de prensa
DEEPULL CIERRA UNA RONDA DE €3,5 MILLONES LIDERADA POR ALTA LIFE SCIENCES Y KURMA. PARTICIPAN AXIS Y SOFIMAC.
DeepUll fue fundada en 2019 por Jordi Carrera y Rafel Bru quienes también fundaron STAT-Dx, compañía q... |
| 06.09.2019 | Xeltis’ closes €10.5 million Series D financing | |
| 15.11.2017 | Xeltis Closes €45 Million in Series C Financing | |
| 15.11.2017 | Xeltis mit Rekordfinanzierung | |
| 11.04.2016 | STAT Diagnostica cierra una ronda de €25M, acuden GildeHC, Kurma, Boehringer, Ysios Capital, CaixaCR, Axis e Idinvest Partners | 11/04/2016
STAT DIAGNOSTICA CIERRA UNA RONDA DE €25M, ACUDEN GILDE HEALTHCARE, KURMA PARTNERS, BOEHRINGER INGELHEIM, YSIOS CAPITAL, CAIXA CAPITAL RISC, AXIS E IDINVEST PARTNERS.
STAT Diagnostica, compañía especializada en el desarrollo de... |
| 17.12.2015 | Xeltis acquires additional €3M in series B financing | |
| 14.10.2015 | Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M) | Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces it has completed a Series A funding round of €19.4M ($21.7M). Ysios Capital, a Spanish investment fund, led the ... |
| - | Ganymed Robotics brings home €21 million to launch surgical robots | French startup that develops computer vision software and robotics technologies for orthopaedic surgeons, Ganymed Robotics has raised €21 million in funding. The oversubscribed Series B round was led by Cathay Health, with participation fro... |
| - | Vivet Therapeutics raises €37.5 million in Series A financing round to advance novel gene therapies for treating inherited metabolic diseases | Paris, France, 4th May 2017 – Vivet Therapeutics (‘Vivet’), an emerging biotechnology company developing novel gene therapies for rare, inherited metabolic diseases, announced it has raised €37.5 million in a Series A financing round. The r... |
| - | Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment | Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, today announced that it has successfully secured €7 million in seed funding. The funding round... |
| - | French digital clinic Charles.co gets a shot of €7 million to make men’s health solutions more accessible | Paris-based digital clinic entirely dedicated to men’s health issues, Charles.co has brought in €7 million in a seed-stage funding. The funding will allow the startup to expand its offerings and build out its team, which has already support... |
| - | French biotech DNA Script raises $200 million, pushes forward with desktop DNA printer | Parisian life sciences technology company DNA Script has raised $200 million in a Series C funding round. The company has developed an alternative to traditional DNA synthesis, a proprietary mechanism it calls Enzymatic DNA Synthesis. This ... |
| - | Parisian startup revolutionising skin cancer screening raises €5 million to accelerate European rollout | Skin cancers affect over 5 million people worldwide each year and patient prognosis continues to be highly dependent on the timing of diagnosis. Attempting to speed up the diagnosis process is Paris-based medtech company Damae Medical. It h... |